Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 6/20 | 0.43 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.41 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.41 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.41 |
| ▸ | GLP1R | P43220 | 8/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | QRFPR | Q96P65 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30481170 | 1.00 | NOD1 (0.43) | NOD1SIRT6SIRT1SLC6A5GLP1R | |
| SCHEMBL29875551 | 0.94 | C3AR1 (0.40) | NOD1SIRT6SIRT1SLC6A5QRFPR | |
| SCHEMBL30471509 | 0.92 | NOD1 (0.46) | NOD1SIRT6SIRT1SLC6A5EPHX2 | |
| SCHEMBL31593243 | 0.90 | SLC15A2 (0.43) | SIRT6SIRT1SLC6A5QRFPR | |
| SCHEMBL5522251 | 0.89 | NOD1 (0.42) | NOD1SIRT6SIRT1SLC6A5GLP1R | |
| SCHEMBL29630536 | 0.88 | QRFPR (0.42) | NOD1QRFPR | |
| SCHEMBL29630598 | 0.88 | QRFPR (0.42) | QRFPR | |
| SCHEMBL17930107 | 0.88 | SLC15A2 (0.47) | SIRT6SIRT1SLC6A5QRFPR | |
| SCHEMBL12646501 | 0.87 | ITGB3 (0.38) | EPHX2QRFPR | |
| SCHEMBL31593280 | 0.87 | NPY4R (0.39) | SIRT6SIRT1QRFPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4444352-A1 | COMPOSITIONS AND METHODS FOR ORAL ADMINISTRATION | IMAGINE PHARMA, LLC (US) | 2024-10-16 | — | — | EP | disclosed |
| WO-2023108126-A9 | COMPOSITIONS AND METHODS FOR ORAL ADMINISTRATION | IMAGINE PHARMA LLC (US) | 2023-08-24 | — | — | WO | disclosed |
| WO-2023108126-A1 | COMPOSITIONS AND METHODS FOR ORAL ADMINISTRATION | IMAGINE PHARMA LLC (US) | 2023-06-15 | — | — | WO | disclosed |